Press "Enter" to skip to content

New patent for Rempex drug VABOMERE

0
Copyright © DrugPatentWatch. Originally published at New patent for Rempex drug VABOMERE

Annual Drug Patent Expirations for VABOMERE
Annual Drug Patent Expirations for VABOMERE

Vabomere is a drug marketed by Rempex and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

Drug patent litigation for VABOMERE.

This drug has forty-two patent family members in twenty-six countries.

The generic ingredient in VABOMERE is meropenem; vaborbactam. One supplier is listed for this compound. Additional details are available on the meropenem; vaborbactam profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Rempex drug VABOMERE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions